Talis Biomedical Corporation (TLIS) Stockholders: Robbins LLP is Investigating TLIS on Behalf of Shareholders
Shareholder rights law firm Robbins LLP is investigating Talis Biomedical Corporation (NASDAQ: TLIS) to determine whether certain Talis officers and directors violated securities laws and breached fiduciary...
Talis Biomedical Provides Business Update and Reports Second Quarter Financial Results
Conference call and webcast today at 4:30pm Eastern/1:30pm Pacific...
Talis Biomedical Corporation (TLIS) Q1 2022 Earnings Call Transcript
TLIS earnings call for the period ending March 31, 2022.
Talis Biomedical to Announce First Quarter 2022 Financial Results on May 10, 2022
MENLO PARK, Calif., April 26, 2022 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation ("TLIS"), a company dedicated to advancing health equity and outcomes...